Abilify Shows Promise in ME/CFS Study (Dian)
- Condition
- ME/CFS
- At worst
- Not stated
- Ill for
- 38 years
- Published
- Mar 2021
Summary
Dian takes Abilify at 4.5 mg along with low-dose naltrexone (LDN), a combination she has used for two years. She has had ME/CFS since a bout of mono as a teenager and is now 54; she went from needing a wheelchair or walker to walking 2 to 4 miles a day, crediting Abilify for gains in energy, stamina and mental clarity, though it also caused increased appetite, a 5 to 10 lb weight gain and worsened anxiety. The improvement had held over the full two years described on the page.
What they credit
Credits Low-dose naltrexone, Other prescription drugs, Low-dose Abilify / aripiprazole, Low-dose naltrexone.
Similar stories
-
Treatments. Yes, they do exist.
In this follow-up post, Encephalogirl (Michelle) lists an expanded regimen: low-dose naltrexone, low-dose Abilify, guanfacine, about nine months of tenofovir as part of a planned minimum one-year antiviral course, six weeks of low-dose rapamycin at 1mg once…
-
Hyperbaric Oxygen Therapy Turns Mathew's Long COVID / ME/CFS / POTS Around
Mathew developed long COVID with ME/CFS and POTS after a COVID infection in February 2020 and cycled through severe crashes for four years, at times 20 hours a day in bed, despite midodrine, low-dose naltrexone, Abilify and Paxlovid. In late 2023 he…
-
Drugs Get Mathew Most of the Way and Hyperbaric Oxygen Does the Rest
Dr Mathew Robinson, a university professor, developed long COVID with ME/CFS and POTS after infection in February 2020 and spent 20-22 hours a day in bed. Midodrine, low-dose Abilify and low-dose naltrexone under Bateman Horne Center care brought him to…
-
Radical Rest and Beyond
The author of Encephalogirl (who signs as Michelle) treats her ME/CFS-related dysautonomia and POTS with guanfacine and low-dose Abilify (titrated from 0.5mg down to 0.25mg after migraines, then back up to 0.5mg), an increased dose of low-dose naltrexone, a…